This study identifies the DNAJB1-PRKACA fusion transcript as a prime source for broadly applicable neoepitopes and provides evidence for their immunotherapeutic efficacy in a single FL-HCC patient. The gene discussed is DNAJB1; the disease is hepatocellular carcinoma.